BSE Sensex surged 209.69 points or 0.38% towards the fag-end of the trading session to settle at record 55,792.27
In early deals, Sensex dropped 150 points or 0.27% to 55,431. NSE Nifty 50 was at 16,545, down 17 points or 0.11%.
Lupin has received tentative approval from the USFDA for its Abbreviated New Drug Application (ANDA) Brivaracetam Tablets
Santosh Meena of Swastika Investmart is positive on PNC Infratech with a target price of Rs Rs 330
Sensex closed the session 145.29 points or 0.26% higher at record 55,582.58. The 30-share BSE index touched a record intra-day high of 55,680.75.
The company has also outlaid a capital expenditure of Rs 3,000 crore for its European operations as its focus is to make the business “stronger”.
On the BSE, Krsnaa Diagnostics opened at Rs 1,025, at a premium of 7.44% or Rs 71 over its issue price of Rs 954 per share.
On the BSE, Devyani International opened for trading at Rs 141, at a premium of 56.67% or Rs 51 over its issue price of Rs 90 per share.
Sectoral indices on the NSE were mixed. Nifty Pharma falling nearly 1% was the top sectoral laggard followed by Nifty Media and and Nifty Auto.
Before one takes the plunge into the vast ocean of investments, it is important to understand the difference between risk and volatility